Nektar Therapeutics
NKTR
#4699
Rank
โ‚ฌ1.99 B
Marketcap
58,40ย โ‚ฌ
Share price
-1.84%
Change (1 day)
16.73%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -โ‚ฌ0.14 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are โ‚ฌ55.63 Million. In 2025 the company made an earning of -โ‚ฌ0.14 Billion a decrease over its 2024 earnings that were of -โ‚ฌ0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ0.14 Billion-3.91%
2025 -โ‚ฌ0.14 Billion30.44%
2024 -โ‚ฌ0.11 Billion-56.85%
2023 -โ‚ฌ0.25 Billion-24.31%
2022 -โ‚ฌ0.32 Billion-30.25%
2021 -โ‚ฌ0.46 Billion17.87%
2020 -โ‚ฌ0.39 Billion0.88%
2019 -โ‚ฌ0.39 Billion-164.46%
2018 โ‚ฌ0.59 B-810.61%
2017 -โ‚ฌ83.62 Million-37.06%
2016 -โ‚ฌ0.14 Billion89.22%
2015 -โ‚ฌ70.21 Million48.22%
2014 -โ‚ฌ47.37 Million-65.93%
2013 -โ‚ฌ0.14 Billion-6.81%
2012 -โ‚ฌ0.15 Billion28.95%
2011 -โ‚ฌ0.12 Billion258.8%
2010 -โ‚ฌ32.26 Million-63.94%
2009 -โ‚ฌ89.45 Million-392.45%
2008 โ‚ฌ30.58 M-211.74%
2007 -โ‚ฌ27.38 Million-79.57%
2006 -โ‚ฌ0.14 Billion-16.9%
2005 -โ‚ฌ0.17 Billion81.53%
2004 -โ‚ฌ88.82 Million54.19%
2003 -โ‚ฌ57.61 Million-33.87%
2002 -โ‚ฌ87.11 Million-9.6%
2001 -โ‚ฌ96.35 Million73.39%
2000 -โ‚ฌ55.57 Million108.9%
1999 -โ‚ฌ26.6 Million39.48%
1998 -โ‚ฌ19.08 Million60.02%
1997 -โ‚ฌ11.92 Million18.05%
1996 -โ‚ฌ10.1 Million31.82%
1995 -โ‚ฌ7.66 Million57.14%
1994 -โ‚ฌ4.88 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ22.60 B-17,168.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ9.21 B-7,058.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.90 B-6,070.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-โ‚ฌ0.45 Billion 233.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ11.44 B-8,740.81%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ12.76 B-9,734.18%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
โ‚ฌ4.6 M-103.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
โ‚ฌ0.20 B-255.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland